PGC1α protein levels were found to be reduced in the Tg2576 mouse model (that overexpresses a mutant form of APP with the Swedish mutation KM670/671NL, which increases Aβ levels and amyloid plaques) [148], and the mRNA in the brain of AD patients correlated with the progression of clinical dementia [149]. This evidence concerns the gene APP and Alzheimer disease.